Cubist Systematic Strategies’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Cubist Systematic Strategies’s Portfolio KRSA Stock Details KRSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-99	Closed	-$24K	–	3595
2021 Q4	$24K	Buy	+99	New	+$4.68K	﹤0.01%	3367
2021 Q3	–	Sell	-122	Closed	-$67K	–	2990
2021 Q2	$67K	Buy	+122	New	+$7.64K	﹤0.01%	2761
2020 Q1	–	Sell	-4	Closed	-$2K	–	2223
2019 Q4	$2K	Buy	+4	New	+$374	﹤0.01%	2386
2019 Q3	–	Sell	-75	Closed	-$121K	–	2261
2019 Q2	$121K	Buy	+75	New	+$21.2K	﹤0.01%	2191

Other funds holding KRSA

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PVI

Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Cubist Systematic Strategies's KRSA Position: Q1 2022 in Review

Cubist Systematic Strategies sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q1 2022, closing a stake of 99 shares — an estimated $24K sold.

Cubist Systematic Strategies first reported a position in KRSA in Q2 2019 and held it in 4 quarters. The position peaked at $121K in Q2 2019. 46 funds tracked by Wall St. Rank hold KRSA as of Q1 2022.

Cubist Systematic Strategies reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Cubist Systematic Strategies sold 99 Korsana Biosciences, Inc. Common Stock shares in Q1 2022, an estimated $24K.
Cubist Systematic Strategies first reported a position in Korsana Biosciences, Inc. Common Stock in Q2 2019 and held it in 4 quarters.
Cubist Systematic Strategies's Korsana Biosciences, Inc. Common Stock position peaked at $121K in Q2 2019.
46 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q1 2022.

Based on Cubist Systematic Strategies's 13F filing for Q1 2022, filed 16 May 2022.